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1200 utility weights associated with cardiovascular events and procedures. 
Stroke accounted for one-third of total identified cardiovascular utilities, 
followed by myocardial infarction (25%), heart failure (17%), and peripheral 
vascular disease (8%). Most (86%) of the utility estimates were derived from 
secondary references (e.g., published literature). Over one-third (36%) of utilities 
identified were elicited using EQ-5D and 14% were estimated with direct time 
trade-off questions. Among the utilities from published studies disclosing 
sample population information, nearly two-thirds (64%) were elicited from 
patients and 25 % from community members. Few studies (n=27 CUAs, 168 utility 
weights) reported utilities for asymptomatic or symptomatic states prior to the 
cardiovascular event or procedure. CONCLUSIONS: Heterogeneity exists in the 
reporting of cardiovascular utility weights. Analysts conducting CUAs using 
secondary references can improve study transparency by reporting relevant 
utility information, such as sample population, sample size, and assessment 
method. In order to better understand the cost-effectiveness of interventions for 
cardiovascular conditions, further research is needed to inform baseline utility 
measurement prior to cardiovascular events or procedures.  
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THE DEVELOPMENT AND VALIDATION OF A REVISED VERSION OF THE 
MEDICAL OUTCOMES STUDY COGNITIVE FUNCTIONING SCALE (MOS-COG-R)  
Yarlas A, White MK, Bjorner JB 
Optum, Lincoln, RI, USA  
OBJECTIVES: Evaluate the psychometric properties of the revised version of the 
Medical Outcomes Study Cognitive Functioning Scale (MOS-Cog-R) using data 
from a representative sample of U.S. adults. METHODS: The 6-item MOS-Cog 
yields a single score representing impairment across a range of cognitive 
functions, including memory, reasoning, attention/concentration, and confusion, 
over the previous four weeks. The MOS-Cog-R introduced several changes: one 
response option was removed; a one-week recall period form was introduced; 
and 0-100 scoring was replaced by norm-based T-scores (mean=50, standard 
deviation=10), standardized using data from a 2009 U.S. internet-based general 
population normative survey to improve interpretability. The psychometric 
properties of both one-week (acute) and four-week (standard) recall forms of the 
MOS-Cog-R were examined within the development sample. Scale reliability was 
evaluated using inter-item correlations and Cronbach’s alpha. Construct validity 
was tested using correlations with relevant continuous criterion variables and 
analysis of covariance models comparing mean MOS-Cog-R scores across levels 
of categorical criterion variables. RESULTS: Acute and standard forms of the 
MOS-Cog-R were completed by 2012 and 2003 respondents, respectively. Both 
forms showed adequate internal consistency reliability (all inter-item 
correlations>0.40; both Cronbach's alphas≥0.89). MOS-Cog-R scores showed 
greater correspondence with mental domains of quality of life than physical 
domains (e.g., correlations for both forms with SF-12v2 mental and physical 
summary scores were ≥0.55 and ≤0.28, respectively). Direction and magnitude of 
correlations with criterion measures of psychological status (e.g., depression, 
anxiety) and health outcomes indicated good convergent validity for both forms. 
Differences in mean scores across respondents stratified by criterion outcomes 
supported adequate discriminant validity of each form. CONCLUSIONS: The 
MOS-Cog-R introduces a number of improvements, including simplified 
responses, the introduction of a one-week recall form, and norm-based scoring 
that enhances interpretability of scores. Both acute and standard recall-period 
forms of the MOS-Cog-R demonstrated good reliability and validity.  
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ESTIMATING AN EQ-5D-3L VALUE SET IN SINGAPORE  
Luo N, Wang P 
National University of Singapore, Singapore, Singapore  
OBJECTIVES: To establish an EQ-5D-3L value set using time trade-off (TTO) 
values directly measured from the general Singaporean population. METHODS: 
The values of 80 EQ-5D-3L health states were directly elicited from a general 
Singaporean population sample using a TTO method modified from the MVH 
protocol. In face-to-face interviews, participants were asked to value a block of 
10 health states. Various linear regression models and model specifications were 
examined to assess their goodness of fit to the data, at both individual and 
aggregated levels, and ability to predict the values for measured and 
unmeasured EQ-5D-3L health states. Goodness of fit was assessed in terms of 
mean absolute error (MAE), numbers of prediction errors larger than 0.05 and 
0.10; while prediction ability was assessed in terms of logic consistency and bias. 
RESULTS: A total of 500 participants provided data for this study. The N3 model 
without a constant using the random-effects estimator exhibited the best fit of 
the data at individual level, predicted values with the least bias, and generated 
logically consistent values for all 243 EQ-5D-5L health states. The MAE was 
0.1227, and 41 out of 80 predicted values had errors less than 0.10 in absolute 
magnitude. Based on this model, the second highest utility value is 0.8867 for 
state 21,111and the lowest value is -0.7284 for state 33,333. CONCLUSIONS: This 
study established the value set of EQ-5D-3L health states for Singapore. The 
value set provides health services researchers in Singapore a useful tool for 
assessing the cost-effectiveness of health technologies and services.  
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VALIDATION AND PSYCHOMETRIC EVALUATION OF A HEALTH CARE 
ORIENTATION ASSESSMENT  
Bushnell DM1, McCarrier KP1, Scanlon M1, Nelson DR2, Martin ML1, Buesching DP2 
1Health Research Associates, Inc., Seattle, WA, USA, 2Eli Lilly and Company, Inc., Indianapolis, 
IN, USA  
OBJECTIVES: The Provider-Dependent Health Care Orientation (PDHCO; Kaplan 
1996) assesses an individual’s orientation towards health and health care and 
measures an individual’s dependence (i.e., passivity) related to health care and 
disease management. We sought to build on prior validation of the instrument 
by evaluating the reproducibility of the PDHCO and testing equivalence between 
paper and electronic administration modes. METHODS: The PDHCO and other 
questionnaires were administered to a sample of adults recruited through web-
based advertisements in 8 U.S. cities. Participants completed the PDHCO on 
paper and computerized formats in a randomized crossover design. A one-week 
retest was completed at home. Reproducibility and mode equivalence were 
assessed using the intraclass correlation coefficient (ICC). Cronbach’s alpha was 
calculated to assess internal consistency. To assess convergent validity, the 
correlation of the PDHCO to the Communication With Physician (CWP) Scale of 
the Chronic Disease Self-Efficacy Scale was calculated. ANOVA was used to 
compare mean PDHCO scores among tertiles of the Health Assertiveness Scale 
(HAS). RESULTS: Of the 230 participants that completed baseline assessment, 228 
(99.1%) completed the one-week retest. The mean age of participants was 44.3 
years, 51.3% were female, and 58.3% were Caucasian. A small number (n=9; 3.9%) 
reported their health as Poor. The mean PDHCO score was 49.7(±14.7), and the 
ICC between paper and computerized administration was 0.887. The ICC for the 
one-week retest of the paper format was 0.913, and the PDHCO was found to be 
internally consistent (Cronbach’s alpha=0.735). Significant correlations were 
found with the CWP (r=-0.246; p<.001), and the instrument discriminated 
between levels of the HAS (p<0.05). CONCLUSIONS: The PDHCO was observed to 
have adequate reproducibility and internal consistency as well as appropriate 
convergent validity. The scale was found to significantly discriminate between 
levels of health assertiveness. Equivalence between paper and web-based 
administration was demonstrated.  
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DEVELOPMENT OF A NEW PATIENT-REPORTED OUTCOME (PRO) INSTRUMENT 
FOR PULMONARY ARTERIAL HYPERTENSION (PAH): THE PULMONARY 
ARTERIAL HYPERTENSION–SYMPTOMS AND IMPACT (PAH-SYMPACT) 
QUESTIONNAIRE  
McCollister D1, Kummer S2, Badesch DB1, Filusch A3, Hunsche E4, Schüler R5, Wiklund I6, 
Peacock A7 
1University of Colorado Denver, Aurora, CO, USA, 2United BioSource Corporation, Bethesda, MD, 
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Allschwil, Switzerland, 5Actelion Pharmaceuticals UK Ltd., London, UK, 6United BioSource 
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OBJECTIVES: In the absence of any pulmonary arterial hypertension (PAH)-
specific PRO instruments developed in accordance with 2009 FDA guidance 
requirements, this qualitative research study was conducted to develop a new 
instrument assessing PAH symptoms and their impacts following the PRO 
guidance. METHODS: Patient inclusion criteria were age 18–80 years and 
symptomatic PAH (WHO Group 1) diagnosed by right-heart catheterization. 
Concept elicitation was based on 5 focus groups, after which saturation of 
emergent concepts was reached. A PRO instrument for PAH symptoms and their 
impacts was drafted, considering input from the international Steering 
Committee as well as translatability and legibility assessments. Two rounds of 
cognitive interviews on the draft PRO were conducted, with instrument revisions 
following each. The study was approved by institutional review boards at 5 US 
sites and participants provided written informed consent. RESULTS: Focus 
groups comprised 25 patients, and 20 additional patients participated in 
cognitive interviews (10 per round). Participants had a mean±SD age of 54±16 
years, were predominantly female (91%), and were diverse in race/ethnicity, 
WHO functional class (FC I/II: 51%, III/IV: 49%), and etiology (associated PAH: 51%, 
idiopathic PAH: 47%, familial PAH: 2%). The draft PRO instrument was found to 
be clear, comprehensive, and relevant to PAH patients in cognitive interviews. 
Items were organized in a draft conceptual framework with 4 symptom domains 
(respiratory symptoms, tiredness, cardiovascular symptoms, other symptoms) 
and 5 impact domains (physical activities, daily activities, social impact, 
cognition, emotional impact). The recall period is the past 24 hours for symptom 
items, and 7 days for impact items. CONCLUSIONS: The draft instrument was 
shown to capture symptoms and their impacts relevant to PAH patients, 
demonstrating content saturation and concept validity. Additional testing is 
needed to confirm the content and psychometric validity of the PAH-SYMPACT 
before use in future clinical practice or studies.  
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USING A LIFE SATISFACTION MEASURE IN THE VALUATION OF HEALTH: A 
CASE STUDY OF MULTIPLE SCLEROSIS  
Suponcic S, DiBonaventura M, Kopenhafer L 
Kantar Health, New York, NY, USA  
OBJECTIVES: The valuation of health is becoming increasingly important for the 
purposes of health technology assessment. However, recent research has 
suggested that traditional preference-based measures for valuing health states 
may be flawed and life satisfaction measures may better represent the patient 
perspective. The current study extended this research by examining the validity 
of a life satisfaction measure among patients with multiple sclerosis (MS). 
METHODS: Data from the Multiple Sclerosis Patient study (N=1000) were used, 
which were collected from an Internet-based survey of patients who self-
reported a diagnosis of MS. Information on demographics, disease and treatment 
history, and health outcomes were collected. A life satisfaction measure was 
included (1=not satisfied to 7=completely satisfied) and examined alongside MS-
specific symptom and quality of life measures. RESULTS: Respondents were 
mostly female (82.8%) with an average age of 48.7 years. Most respondents had 
relapsing remitting MS (89.0%). The mean life satisfaction scores were 4.87 
(SD=1.26; IQR:4-6). Only small effects were observed between life satisfaction and 
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symptom-related disability measures such as the Patient-Determined Disease 
Steps measure (r=-0.19) and the Multiple Sclerosis Rating Scale-Revised (r=-0.26). 
Although similarly-sized effects were observed with activities of daily living and 
symptom subscales of the MusiQoL (rs = 0.31, both p<0.05), much stronger 
relationships with psychological well-being (r=0.47), sentimental and sexual life 
(r=0.44), and coping (r=0.42; all p<0.05) were observed. CONCLUSIONS: Disability, 
symptom, and activity measures were only modestly related to life satisfaction 
among patients with MS. Conversely, psychological, emotional, and sexual 
factors were much more strongly associated. These results suggest that the 
domains of traditional preference-based measures may not ultimately focus on 
those that matter most for the patient. Further research should continue to 
examine the importance of alternative measures to most accurately value health 
states.  
 
PRM122  
RESULTS FROM A D-EFFICIENT DISCRETE CHOICE EXPERIMENT DESIGN AND 
PROTOCOL WITH CHOICE SETS OF 3 STATES EACH TO ELICIT AN EQ-5D-3L 
VALUE SET  
Bailey H 
The University of the West Indies, St. Augustine, Trinidad and Tobago  
OBJECTIVES: Discrete Choice Experiments (DCEs) have received considerable 
interest in EQ-5D valuations because these methods are simple and choice 
based. Some investigations using DCEs to develop EQ-5D Value Sets include 
implausible states. The DCE literature discourages the use of implausible 
options, citing the links between cognitive burden (facing respondents) and 
random variability in responses. It has been suggested that giving DCE 
respondents choice sets with more than 2 alternatives may improve respondent 
effort/concentration. METHODS: A D-Efficient DCE design for EQ-5D-3L 
comprising 15 choice sets of 3 alternatives each, that excluded states which 
combine a ‘3’ on Mobility with a ‘1’ on either Usual Activities, or Self Care or both 
was developed. As a pilot test, and as a first step towards developing an on-line 
elicitation exercise, an elicitation exercise was put into a Microsoft PowerPoint 
file which was sent out to 189 respondents at various work locations in Trinidad 
and Tobago with a submission deadline of 2 weeks. The elicitation process was 
based on a protocol using sequential comparisons that break the choice process 
into s series of simple ranking steps. RESULTS: Sixty-five Respondents returned 
DCE results within the 2 week period of which the results from 43 respondents 
were useable (66%). A utility function was estimated based on data from the 43 
useable files. This produced an internally valid model with all coefficients 
bearing the correct signs, and relative magnitudes, and all significant to the 5% 
level. CONCLUSIONS: This DCE design allows for EQ-5D-3L valuation studies that 
can be conducted with small samples (no blocking) and it avoids the use of 
implausible states. It introduces a DCE protocol that allows respondents to easily 
make choices out of choice sets comprising 3 EQ-5D-3L States. Increasing the 
number of alternatives in each choice set allows for designs with fewer choice 
sets.  
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HEALTH RELATED QUALITY OF LIFE (HRQOL) OF ARGENTINE POPULATION: 
RESULTS FROM THE NATIONAL HEALTH RISKS FACTOR SURVEY  
Augustovski F1, Rey-Ares L2, Gibbons L3 
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Buenos Aires, Argentina  
OBJECTIVES: To describe general population self reported visual analog scale 
(SR-VAS), as well as time-trade off (TTO) and visual analog scale (VAS) preference 
values (PV) by age groups and gender. METHODS: In 2009, the second “Health 
Risks Factors National Survey” was undertaken in Argentina, including 34,728 
subjects, age 18-65 yrs, randomly selected from all Argentine provinces with a 
probabilistic multi-stage sample design. The expanded population was 
24,434,595. Data were obtained on sociodemographics, health risks factors, and 
health status (EQ-5D and the general health question of SF-36). PV were assigned 
using weights derived from a previous local study. RESULTS: Over 80% of the 
population reported being healthy (11.19% reported health status as excellent, 
26.88% as very good and 42.68% as good), whereas 19.25% of the population 
reported a regular or poor health. The presence of limitations in each EQ-5D 
domains varied from 2.28% in personal care to 30.15% in Pain/Discomfort. The 
presence of limitations was higher in women (3.14% in personal care and 33.38 in 
Pain/Discomfort). The population-weighted mean of the SR-VAS was 76.49 
(95%CI 76.17-76.82). Utilities of the EQ-5D based on preferences in Argentina 
were 0.881 (95%CI 0.878-0,884) for VAS and 0.91 (95%CI% 0.907-0.913) for TTO. All 
values were systematically lower in women. Regarding the differences between 
age groups, values tended to decrease consistently with the increasing of age. 
There were no significant differences between results of the first survey 
conducted in 2005 and the second one in 2009. CONCLUSIONS: There are few 
surveys in Latin America that incorporated the EQ-5D tool to describe general 
population health status and Argentina is one of the few Latin American 
countries that derived local preferences based on TTO and VAS methods. These 
results can serve as a benchmark for future population studies and also as inputs 
for cost-utility analysis of health technologies.  
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EXAMINATION OF PREFERENCES ELICITED FROM THE GENERAL PUBLIC: 
SUBGROUP COMPARISONS OF RESULTS FROM THE TIME TRADE-OFF AND 
STANDARD GAMBLE INSTRUMENTS  
Iskedjian M1, Navarro V2, Farah B3, Berbari J3, Walker JH4, Le Lorier J1 
1Université de Montréal, Montréal, QC, Canada, 2PharmIdeas Europe SAS, Lyon, France, 
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OBJECTIVES: The time trade-off (TTO) and the standard gamble (SG) are two 
methods used for the direct measurement of health-related quality of life, 
expressed as health utilities (HU), among the general public. Significant overall 
correlation was observed in a previous systematic review comparing TTO and SG 
values reported by the general public (19 pertinent publications, 77 study arms 
and 24 diseases). In the present analysis, correlation was further explored among 
specific demographic, clinical and analytic subgroups. METHODS: When a 
sufficient sample of study arms was available, Spearman’s rank correlation test 
was applied to test the correlation between mean or median TTO and SG by 
sorting the TTO values in increasing increments of 0.1, based on the following 
subgroups: incremental HU, disease, gender, age, income, education level and 
employment status. Significance was defined as p-value<0.05. RESULTS: 
Significant positive correlation was observed between mean TTO and SG values 
for all increments of TTO except when TTO<0.5 (r = 0.429), for ocular disease (r = 
0.976), skin disease (r = 0.964) and arthritis (r = 0.956). A post-hoc analysis 
quadrupling the sample of studies with TTO<0.5 resulted in significant positive 
correlation, indicating that the lack of significant correlation was possibly due to 
the scarcity of studies. The series of subgroup analyses focusing on median 
incremental HU values or median HU values associated with skin disease 
resulted in similar findings to the analysis of means. No analysis of demographic 
subgroups could be undertaken due to the limited study sample. CONCLUSIONS: 
A correlation between TTO and SG outcomes reported by members of the general 
public was observed for numerous subgroups. It is possible that correlation 
would have been observed in additional subgroups, but was not, due to the 
limited study sample.  
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CROSS-CULTURAL ADAPTATION OF THE HAEMO-QOL QUESTIONNAIRE INTO 
28 LANGUAGES  
Von Mackensen S1, Gil Campos I2, Acquadro C3, Strandberg-Larsen M4, Fuller DS5 
1University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, 2MAPI Institute, Lyon, 
France, 3MAPI Research Trust, Lyon, France, 4Novo Nordisk A/S, Søborg, Denmark, 5MAPI 
Institute, Philadelphia, PA, USA  
OBJECTIVES: The Haemo-QoL questionnaire was developed to assess health-
related quality-of-life (HRQoL) in children and adolescents with haemophilia. 
Three different age-group versions (4–7, 8–12, 13–16 years) are available as well 
as three corresponding proxy versions for their parents. The original 
questionnaire was developed in German. Since capturing HRQoL aspects of 
haemophilia care has become an integrated part of clinical trials in this field, it is 
important to ensure that the questionnaires used are linguistically validated for 
international use. The objective of this study is to present the cross-cultural 
adaptation of the Haemo-QoL into 28 languages representing six different 
language families (Indo-European, Ural-Altaic, Afro-Asiatic, Japonic, Sino-
Tibetan, and Austronesian). METHODS: A standard multi-step methodology was 
used for translation and cultural adaptation: 1. Development of a concept list; 2. 
Forward/backward translation (or adaptation step or quality check); 3. Review of 
the backward translation and report by the developer of the original instrument; 
and 4. Review of the translation by a clinician. Difficulties encountered during 
the process were categorized as Grammatical, Idiomatic, Semantic/Conceptual, 
and Cultural. RESULTS: Fifteen items raised discussions for semantic (12 items), 
cultural (2 items), and idiomatic reasons (1 item). For instance, the statement “I 
had to refrain from sports like rollerblading or soccer” raised cultural issues. The 
examples of sports had to be culturally adapted, and became “rugby or soccer” 
(in South African English), or “ice-skating or sports like soccer” (in Mandarin). 
Further examples will be presented. CONCLUSIONS: The cross-cultural 
adaptation of the Haemo-QoL into 28 languages required an international 
collaboration and enabled the production of conceptually equivalent and 
culturally appropriate tools. The same process was used for the Haem-A-QoL (for 
adults) and the treatment satisfaction questionnaire (Hemo-Sat). When applied, 
these linguistically validated tools will provide insights into an area of 
haemophilia not well understood in the past.  
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BENCHMARKS FOR INTERPRETATION OF SCORE DIFFERENCES ON THE SF-36 
HEALTH SURVEY  
Bjorner JB1, Wolden M2, Gundgaard J2, Bayliss MS1, Miller K1 
1Optum, Lincoln, RI, USA, 2Novo Nordisk A/S, Søborg, Denmark  
OBJECTIVES: Patient-reported outcomes (PROs) are widely used in clinical 
research. However, results on score differences may be hard to interpret  
if clinicians are unfamiliar with the assessment tools and lack benchmarks for 
interpretation of results. This study aims to estimate clinical and social 
benchmarks for interpretation of score differences on the SF-36 Health Survey 
and to test whether the interpretation depends on score level and patient 
background characteristics. METHODS: Using survival and logistic regression 
models, we reanalyzed data from three US cohort studies: the Medical Outcomes 
Study (N=3,445), the Medicare Health Outcomes Survey (N=78,183), and the 
QualityMetric 2009 Norming Study (N=4,040). Outcome variables were mortality, 
hospitalization, current inability to work, and loss of ability to work. RESULTS: 
Benchmarks were robust across types of disease and for people with or without 
chronic disease. However, the benchmarks did vary according to age and score 
level. A one-point lower score on the PF, GH and PCS scales was associated  
with a 1.05-1.09 relative risk (RR) of mortality for the typical chronic disease 
patient, with stronger associations in the younger age groups. For several scales 
(PF, RP, BP, GH, VT, SF, and RE), the associations with mortality also depended on 
score level, with stronger associations in the lower score ranges (i.e. patients in 
worse health). A one-point lower score on the PF, RP, BP, GH, VT, SF, and  
